Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Lymphangioleiomyomatosis (LAM)”

51 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 51 results

Not applicableStudy completedNCT02325505
What this trial is testing

Characterization of Patients With Tuberous Sclerosis Complex, Lymphangioleiomyomatosis and Angiomyolipoma

Who this might be right for
Tuberous SclerosisLymphangioleiomyomatosisAngiomyolipoma
InCor Heart Institute 200
Post-approval studies (Phase 4)Study completedNCT03525834
What this trial is testing

Safety and Efficacy of Everolimus (Afinitor®) in Chinese Adult Patients With Angiomyolipoma Associated With Tuberous Sclerosis Complex.

Who this might be right for
Renal Angiomyolipoma
Novartis Pharmaceuticals 40
Not applicableLooking for participantsNCT05676099
What this trial is testing

TSC Biosample Repository and Natural History Database

Who this might be right for
Tuberous SclerosisLymphangioleiomyomatosis
National Tuberous Sclerosis Association 5,000
Large-scale testing (Phase 3)Study completedNCT00414648
What this trial is testing

Efficacy and Safety of Sirolimus in LAM

Who this might be right for
Lymphangioleiomyomatosis
University of Cincinnati 89
Large-scale testing (Phase 3)Study completedNCT00790400
What this trial is testing

Efficacy and Safety of RAD001 in Patients Aged 18 and Over With Angiomyolipoma Associated With Either Tuberous Sclerosis Complex (TSC) or Sporadic Lymphangioleiomyomatosis (LAM)

Who this might be right for
Tuberous Sclerosis Complex (TSC)Lymphangioleiomyomatosis (LAM)
Novartis Pharmaceuticals 118
Not applicableStudy completedNCT02009241
What this trial is testing

Pulmonary Rehabilitation in Lymphangioleiomyomatosis

Who this might be right for
Lymphangioleiomyomatosis
University of Sao Paulo General Hospital 40
Not applicableStudy completedNCT00001869
What this trial is testing

Official Record of Patients Diagnosed With Lymphangioleiomyomatosis (LAM)

Who this might be right for
Leiomyomatosis
National Heart, Lung, and Blood Institute (NHLBI) 400
Testing effectiveness (Phase 2)Study completedNCT00457964
What this trial is testing

RAD001 Therapy of Angiomyolipomata in Patients With TS Complex and Sporadic LAM

Who this might be right for
Tuberous SclerosisLymphangioleiomyomatosis
Children's Hospital Medical Center, Cincinnati 36
Early research (Phase 1)UnknownNCT04273334
What this trial is testing

Application of 68Ga NEB PET Imaging in the Diagnosis and Evaluation of Lymphatic Disorders

Who this might be right for
Lymphatic Disorders
Peking Union Medical College Hospital 90
Testing effectiveness (Phase 2)UnknownNCT00490789
What this trial is testing

Trial of Efficacy and Safety of Sirolimus in Tuberous Sclerosis and LAM

Who this might be right for
Tuberous SclerosisLymphangioleiomyomatosis
Cardiff University 14
Not applicableUnknownNCT04577937
What this trial is testing

Sleep Patterns in Patients Affected by Lymphangioleiomiomatosis

Who this might be right for
LymphangioleiomyomatosisSleep DisorderSleep Apnea Syndromes+1 more
dr. Stefano Nava 15
Not applicableStudy completedNCT05323370
What this trial is testing

Lymphangioleiomyomatosis, a Study on Cathepsin K

Who this might be right for
LymphangioleiomyomatosisTuberous Sclerosis Complex
University Hospital, Tours 19
Not applicableLooking for participantsNCT01484236
What this trial is testing

National Lymphangioleiomyomatosis Registry, France

Who this might be right for
Lymphangioleiomyomatosis
Vincent COTTIN 200
Post-approval studies (Phase 4)Study completedNCT00989742
What this trial is testing

Doxycycline In Lymphangioleiomyomatosis (LAM)

Who this might be right for
LymphangioleiomyomatosisTuberous Sclerosis
University of Nottingham 24
Testing effectiveness (Phase 2)Active Not RecruitingNCT05467397
What this trial is testing

Feasibility of [11C]Acetate-PET in LAM and TSC

Who this might be right for
LymphangioleiomyomatosisTuberous Sclerosis Complex
Brigham and Women's Hospital 7
Not applicableStudy completedNCT00960895
What this trial is testing

Pulmonary Hypertension in Lymphangioleiomyomatosis

Who this might be right for
LymphangioleiomyomatosisPulmonary Hypertension
Groupe d'Etudes et de Recherche sur les Maladies Orphelines Pulmonaires 20
Testing effectiveness (Phase 2)Looking for participantsNCT01799538
What this trial is testing

Nebulized or Inhaled Albuterol for Lymphangioleiomyomatosis

Who this might be right for
Lymphangioleiomyomatosis
National Heart, Lung, and Blood Institute (NHLBI) 100
Testing effectiveness (Phase 2)UnknownNCT05190627
What this trial is testing

Effect of Loratadine in Lymphangioleiomyomatosis

Who this might be right for
Lymphangioleiomyomatosis
Institut d'Investigació Biomèdica de Bellvitge 62
Not applicableLooking for participantsNCT02432560
What this trial is testing

Safety and Durability of Sirolimus for Treatment of LAM

Who this might be right for
Lymphangioleiomyomatosis
University of Cincinnati 600
Not applicableLooking for participantsNCT07304856
What this trial is testing

Role of Extracellular Vesicles as Biomarkers of Pulmonary Involvement in Patients With Lymphangioleiomyomatosis and Tuberous Sclerosis Complex

Who this might be right for
Lymphangioleiomyomatosis (LAM)Extracellular Vesicles; Generation and Function
University of Milan 80
Load More Results